Edition:
United Kingdom

Vectura Group PLC (VEC.L)

VEC.L on London Stock Exchange

78.40GBp
16 Nov 2018
Change (% chg)

0.90 (+1.16%)
Prev Close
77.50
Open
76.80
Day's High
78.65
Day's Low
75.90
Volume
819,714
Avg. Vol
1,102,510
52-wk High
127.22
52-wk Low
67.20

Latest Key Developments (Source: Significant Developments)

Vectura Says Hard Brexit Could Increase Costs, Supply Chain Disruptions
Tuesday, 11 Sep 2018 

Sept 11 (Reuters) - Vectura Group PLC ::INTERIM RESULTS.GUIDANCE FOR RESEARCH AND DEVELOPMENT COSTS OF £55-65M FOR 2018 REMAINS UNCHANGED.HY ADJUSTED EBITDA OF £24.6M IS UP 51.9% VERSUS H1 2017.BOARD LOOKS FORWARD TO STRONG REPORTED PERFORMANCE IN H2.MAINTAINS ITS 2018 REVENUE GROWTH EXPECTATIONS.HY LOSS BEFORE TAX 29.9 MILLION STG VERSUS LOSS OF 44.5 MILLION STG YEAR AGO."BREXIT UNCERTAINTY" HAS INCREASED IN H1 2018 DUE TO A HIGHER PROBABILITY OF UK EXITING EU WITHOUT A DEAL.CONTINUES TO MONITOR IMPACT OF HARD BREXIT RISK, AND HAS MITIGATION PLANS IN PLACE.BREXIT COULD RESULT IN AN INCREASED COST OF OPERATIONS FOR GROUP AND POTENTIAL DISRUPTION TO PARTNER SUPPLY CHAINS.CONTINUING TO REVIEW STOCK LEVELS WITH ITS PARTNERS FOR BOTH FINISHED PRODUCT AND KEY COMPONENTS AND PLANNING APPROPRIATELY.  Full Article

Vectura Appoints Paul Fry As CFO
Monday, 16 Jul 2018 

July 16 (Reuters) - Vectura Group PLC ::VECTURA APPOINTS PAUL FRY AS CFO.PAUL SUCCEEDS ANDREW DERODRA WHO, AS PREVIOUSLY ANNOUNCED, LEAVES GROUP AND BOARD ON 31 JULY 2018.  Full Article

Sosei Says Does Not Intend To Make An Offer For Vectura
Tuesday, 24 Apr 2018 

April 24 (Reuters) - Sosei Group Corp::STATEMENT RE PRESS COMMENT.CONFIRMS THAT IT DOES NOT INTEND TO MAKE AN OFFER FOR VECTURA.SOSEI WILL, EXCEPT WITH CONSENT OF UK PANEL ON TAKEOVERS AND MERGERS, BE BOUND BY RESTRICTIONS CONTAINED IN RULE 2.8 OF CODE.  Full Article

Vectura Says CFO Decided To Leave Group
Friday, 20 Apr 2018 

April 20 (Reuters) - Vectura Group PLC ::CHIEF FINANCIAL OFFICER AND EXECUTIVE DIRECTOR ANDREW DERODRA HAS DECIDED TO LEAVE GROUP.A SEARCH FOR HIS REPLACEMENT IS UNDERWAY AND GROUP WILL PROVIDE AN UPDATE ON HIS SUCCESSOR IN DUE COURSE.ANDREW WILL REMAIN IN HIS POSITION AT VECTURA AND ON BOARD UNTIL END OF JULY IN ORDER TO ENSURE A SMOOTH TRANSITION PROCESS.  Full Article

Vectura Group Anticipates FY 2017 Revenue In Line With Board's Expectations
Thursday, 4 Jan 2018 

Jan 4 (Reuters) - Vectura Group Plc ::FULL YEAR 2017 REVENUE ANTICIPATED TO BE IN LINE WITH BOARD'S EXPECTATIONS.FLUTIFORM PRODUCT SUPPLY REVENUE IN H2 2017 IS IN LINE WITH GUIDANCE PROVIDED.FLUTIFORMQ3 1 IN-MARKET NET SALES WERE EUR 47.8 MILLION 2 , UP 12% AT CONSTANT EXCHANGE RATES.ULTIBRO Q3 1 NET SALES OF $101 MILLION, WITH 18% GROWTH IN EUROPE YEAR-ON-YEAR.ROYALTIES FROM GSK ELLIPTA® PRODUCTS ACHIEVED £9 MILLION ANNUAL CAP IN Q3.WERE CURRENT EXCHANGE RATES TO CONTINUE THROUGH 2018, STERLING REPORTED REVENUES WOULD BE REDUCED BY APPROXIMATELY £5.0 MILLION.RESEARCH AND DEVELOPMENT COSTS IN 2018 ARE EXPECTED TO REDUCE TO £55 MILLION - £65 MILLION (PREVIOUS 2018 GUIDANCE: £65 MILLION - £75 MILLION).  Full Article

Hikma boosts revenue outlook again, shares climb

Nov 8 Jordanian drugmaker Hikma Pharmaceuticals raised full-year revenue expectations for its injectables division, its largest unit, for the second time in three months as it supplies more opioid painkillers amid a shortage in the United States.